Posts

ABBV-101 by AbbVie for Relapsed Chronic Lymphocytic Leu...

ABBV-101 is under clinical development by AbbVie and currently in Phase I for Re...

CC-95775 by Bristol-Myers Squibb for Solid Tumor: Likel...

CC-95775 is under clinical development by Bristol-Myers Squibb and currently in ...

MesoCancerVac by Amphera for Metastatic Pancreatic Canc...

MesoCancerVac is under clinical development by Amphera and currently in Phase I ...

AC-0676 by Accutar Biotechnology for Follicular Lymphom...

AC-0676 is under clinical development by Accutar Biotechnology and currently in ...

Selinexor by Karyopharm Therapeutics for Osteosarcoma: ...

Selinexor is under clinical development by Karyopharm Therapeutics and currently...

ORIN-1001 by Shanghai Fosun Pharmaceutical (Group) for ...

ORIN-1001 is under clinical development by Shanghai Fosun Pharmaceutical (Group)...

CJ-15314 by HK inno.N for Atopic Dermatitis (Atopic Ecz...

CJ-15314 is under clinical development by HK inno.N and currently in Phase I for...

AMG-305 by Amgen for Breast Cancer: Likelihood of Approval

AMG-305 is under clinical development by Amgen and currently in Phase I for Brea...

Opinion: Listen: Is the medical system ready for Alzhei...

Leqembi is a game-changer for Alzheimer's. But the health care system needs to c...

Opinion: Sen. Bill Cassidy: Smart, practical ways to lo...

The physician turned senator on how to balance the need to lower drug prices whi...

STAT+: Novo Nordisk bought prescribers over 450,000 mea...

Novo Nordisk bought 457,222 meals to educate doctors about its drugs like Ozempi...

STAT+: FDA approves first Alzheimer’s therapy shown to ...

The FDA has granted full approval to the first therapy for Alzheimer’s disease c...

STAT+: Generic group sues Minnesota over a drug pricing...

The generic trade group argued the “draconian regulations” come at a time when t...

Why depression after traumatic brain injury is distinct...

Depression after traumatic brain injury is distinct, a new study finds, and ther...

STAT+: Pharmalittle: Next big hope for Alzheimer’s migh...

Critics say any positive impact from the Alzheimer's drug Leqembi will not benef...

Drinking water from nearly half of U.S. faucets likely ...

The study “can be used to evaluate risk of exposure and inform decisions about w...